TrialInvestigational new drugs2017

A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer.

M Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.